BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21301782)

  • 1. Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice.
    Kawao N; Nagai N; Tamura Y; Okada K; Yano M; Suzuki Y; Umemura K; Ueshima S; Matsuo O
    Thromb Haemost; 2011 May; 105(5):892-900. PubMed ID: 21301782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo.
    Kawao N; Nagai N; Tamura Y; Horiuchi Y; Okumoto K; Okada K; Suzuki Y; Umemura K; Yano M; Ueshima S; Kaji H; Matsuo O
    Thromb Haemost; 2012 Apr; 107(4):749-59. PubMed ID: 22318286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of plasminogen in macrophage accumulation during liver repair.
    Kawao N; Nagai N; Okada K; Okumoto K; Ueshima S; Matsuo O
    Thromb Res; 2010 May; 125(5):e214-21. PubMed ID: 20064655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
    Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
    Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
    Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
    Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair in Diabetic Female Mice.
    Shimoide T; Kawao N; Tamura Y; Okada K; Horiuchi Y; Okumoto K; Kurashimo S; Ishida M; Tatsumi K; Matsuo O; Kaji H
    Endocrinology; 2018 Apr; 159(4):1875-1885. PubMed ID: 29534207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells.
    Oszajca K; Bieniasz M; Brown G; Swiatkowska M; Bartkowiak J; Szemraj J
    Biochem Cell Biol; 2008 Dec; 86(6):477-86. PubMed ID: 19088796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
    Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T
    Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
    Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
    Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S; Fukao H; Okada K; Matsuo O
    Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
    Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
    Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.
    Pyke C; Kristensen P; Ralfkiaer E; Grøndahl-Hansen J; Eriksen J; Blasi F; Danø K
    Am J Pathol; 1991 May; 138(5):1059-67. PubMed ID: 1850957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soya protein hydrolysates modify the expression of various pro-inflammatory genes induced by fatty acids in ovine phagocytes.
    Politis I; Theodorou G; Lampidonis AD; Chronopoulou R; Baldi A
    Br J Nutr; 2012 Oct; 108(7):1246-55. PubMed ID: 22172314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.
    Sier CF; Quax PH; Vloedgraven HJ; Verheijen JH; Griffioen G; Ganesh S; Lamers CB; Verspaget HW
    Invasion Metastasis; 1993; 13(6):277-88. PubMed ID: 7860221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of urokinase-type plasminogen activator in leukocyte infiltration and inflammatory responses in mice corneas treated with lipopolysaccharide.
    Sugioka K; Kodama A; Yoshida K; Okada K; Mishima H; Aomatsu K; Matsuo O; Shimomura Y
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5338-50. PubMed ID: 25061113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.